Clinical Trials Logo

Muscular Atrophy clinical trials

View clinical trials related to Muscular Atrophy.

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT02865109 No longer available - Clinical trials for Infantile-onset Spinal Muscular Atrophy

Expanded Access Program (EAP) for Nusinersen in Participants With Infantile-onset (Consistent With Type 1) Spinal Muscular Atrophy (SMA)

Start date: n/a
Phase:
Study type: Expanded Access

To provide access to nusinersen to eligible patients with Infantile-onset Spinal Muscular Atrophy (SMA) (consistent with Type 1) to address a high-unmet medical need.